Annette Marcantonio
Corporate Officer/Principal at JASPER THERAPEUTICS, INC.
Profile
Annette Marcantonio is currently the Vice President of Clinical Operations at Jasper Therapeutics, Inc. Prior to this, she held the same position at Aimmune Therapeutics, Inc. from 2016 to 2020.
She received her undergraduate degree from Loyola Marymount University.
Annette Marcantonio active positions
| Companies | Position | Start |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2023 |
Former positions of Annette Marcantonio
| Companies | Position | End |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 30/09/2020 |
Training of Annette Marcantonio
| Loyola Marymount University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Private companies | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Stock Market
- Insiders
- Annette Marcantonio
